Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 185,880	$ 244,440
Accounts receivable, net	73,833us-gaap_AccountsReceivableNetCurrent	158,732us-gaap_AccountsReceivableNetCurrent
Inventories	166,761us-gaap_InventoryNet	154,687us-gaap_InventoryNet
Prepaid expenses and other current assets	26,076	28,255
Deferred income tax assets	68,057us-gaap_DeferredTaxAssetsNetCurrent	66,936us-gaap_DeferredTaxAssetsNetCurrent
Total current assets	520,607us-gaap_AssetsCurrent	653,050us-gaap_AssetsCurrent
Property, plant and equipment, net	223,748us-gaap_PropertyPlantAndEquipmentNet	217,314us-gaap_PropertyPlantAndEquipmentNet
Intangible assets, net	1,006,177	1,040,753
Goodwill	1,036,958us-gaap_Goodwill	1,012,108us-gaap_Goodwill
Other assets	88,445us-gaap_OtherAssetsNoncurrent	83,909us-gaap_OtherAssetsNoncurrent
Total assets	2,875,935us-gaap_Assets	3,007,134us-gaap_Assets
Current liabilities:
Current portion of long-term debt	18,753us-gaap_LongTermDebtCurrent	14,503us-gaap_LongTermDebtCurrent
Accounts payable	81,793us-gaap_AccountsPayableCurrent	79,987us-gaap_AccountsPayableCurrent
Accrued salaries and employee benefits	17,517	32,246
Accrued legal fees	12,839us-gaap_LitigationReserveCurrent	4,864us-gaap_LitigationReserveCurrent
Accrued interest payable	16,563us-gaap_InterestPayableCurrent	7,529us-gaap_InterestPayableCurrent
Accrued expenses and other current liabilities	19,556us-gaap_OtherLiabilitiesCurrent	42,815us-gaap_OtherLiabilitiesCurrent
Total current liabilities	235,781us-gaap_LiabilitiesCurrent	277,804us-gaap_LiabilitiesCurrent
Long-term liabilities	21,910us-gaap_LiabilitiesNoncurrent	17,004us-gaap_LiabilitiesNoncurrent
Non-current deferred tax liabilities	233,286	247,191
Long-term debt, less current portion	2,318,510us-gaap_LongTermDebtNoncurrent	1,904,069us-gaap_LongTermDebtNoncurrent
Commitments and contingencies
Stockholders' equity:
Common stock, $0.001 par value per share, 100 shares authorized and issued	0us-gaap_CommonStockValue	0us-gaap_CommonStockValue
Additional paid-in capital	295,476us-gaap_AdditionalPaidInCapital	808,647us-gaap_AdditionalPaidInCapital
Accumulated deficit	(223,648)	(243,933)
Accumulated other comprehensive loss	(5,380)	(3,648)
Total stockholders' equity	66,448us-gaap_StockholdersEquity	561,066us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity	2,875,935	3,007,134
Other Regulatory Assets (Liabilities) [Member]
Current liabilities:
Accrued government pricing liabilities	23,942	42,647
Distribution Agreement Partner [Member]
Current liabilities:
Payables due to distribution agreement partners	$ 44,818	$ 53,213

PAR PHARMACEUTICAL COMPANIES, INC. 10-Q